C.P. Denton

881 total citations
28 papers, 620 citations indexed

About

C.P. Denton is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, C.P. Denton has authored 28 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in C.P. Denton's work include Systemic Sclerosis and Related Diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). C.P. Denton is often cited by papers focused on Systemic Sclerosis and Related Diseases (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). C.P. Denton collaborates with scholars based in United Kingdom, France and Italy. C.P. Denton's co-authors include C. M. Black, Svetlana I. Nihtyanova, Shiwen Xu, V.J. Swale, M.H.A. Rustin, Marco Matucci‐Cerinic, Alastair Forbes, Richard Stratton, Nora Thoua and Andrew Leask and has published in prestigious journals such as Annals of Internal Medicine, Gut and Brain Research.

In The Last Decade

C.P. Denton

26 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C.P. Denton United Kingdom 11 461 173 160 155 128 28 620
Giuseppina Abignano United Kingdom 17 477 1.0× 114 0.7× 180 1.1× 221 1.4× 147 1.1× 59 727
Karin Melsens Belgium 15 606 1.3× 186 1.1× 146 0.9× 265 1.7× 117 0.9× 29 724
Ikuko Hayakawa Japan 13 366 0.8× 92 0.5× 209 1.3× 123 0.8× 174 1.4× 23 637
Cecília Varjú Hungary 13 423 0.9× 114 0.7× 108 0.7× 187 1.2× 247 1.9× 27 605
Angela Kill Germany 7 308 0.7× 109 0.6× 209 1.3× 74 0.5× 143 1.1× 8 549
Solène Tatibouet Canada 12 566 1.2× 187 1.1× 209 1.3× 236 1.5× 226 1.8× 16 648
G. Riemekasten Germany 12 396 0.9× 147 0.8× 217 1.4× 156 1.0× 82 0.6× 22 681
Tatiana Nevskaya Canada 14 293 0.6× 146 0.8× 162 1.0× 123 0.8× 63 0.5× 33 641
Catherine Alderdice Canada 5 259 0.6× 109 0.6× 135 0.8× 121 0.8× 94 0.7× 7 470
Satoshi Ebata Japan 15 449 1.0× 218 1.3× 211 1.3× 135 0.9× 241 1.9× 36 655

Countries citing papers authored by C.P. Denton

Since Specialization
Citations

This map shows the geographic impact of C.P. Denton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.P. Denton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.P. Denton more than expected).

Fields of papers citing papers by C.P. Denton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.P. Denton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.P. Denton. The network helps show where C.P. Denton may publish in the future.

Co-authorship network of co-authors of C.P. Denton

This figure shows the co-authorship network connecting the top 25 collaborators of C.P. Denton. A scholar is included among the top collaborators of C.P. Denton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.P. Denton. C.P. Denton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lazzaroni, Maria Grazia, Corrado Campochiaro, Emiliano Marasco, et al.. (2020). SAT0328 OUTCOME OF INTERSTITIAL LUNG DISEASE (ILD) IN ANTI-PM/SCL PATIENTS WITH SYSTEMIC SCLEROSIS: RESULTS FROM AN EUSTAR CASE-CONTROL STUDY.. Annals of the Rheumatic Diseases. 79. 1109–1110. 1 indexed citations
3.
Denton, C.P., et al.. (2018). THU0398 Unexplained iron deficiency is frequent in systemic sclerosis. Annals of the Rheumatic Diseases. 77. 413–414. 1 indexed citations
4.
Griffin, Michelle, et al.. (2016). FRI0287 The Use of A Dorsal Approach for The Injection of Botulinum Toxin A in The Treatment of Raynauds Phenomenon Secondary To Scleroderma. Annals of the Rheumatic Diseases. 75. 539–539. 1 indexed citations
5.
Khanna, Dinesh, C.P. Denton, Angelika Jahreis, et al.. (2015). OP0054 Safety and Efficacy of Subcutaneous Tocilizumab in Adults with Systemic Sclerosis: Week 48 Data from the Fasscinate Trial. Annals of the Rheumatic Diseases. 74. 87–88. 9 indexed citations
6.
7.
Matucci‐Cerinic, Marco, Loı̈c Guillevin, C.P. Denton, et al.. (2012). FRI0435 Management of digital ulcer disease varies across europe: Findings from the duo registry. Annals of the Rheumatic Diseases. 71. 461–461. 1 indexed citations
8.
Thoua, Nora, Alexis Schizas, Alastair Forbes, C.P. Denton, & Anton Emmanuel. (2011). Internal anal sphincter atrophy in patients with systemic sclerosis. Lara D. Veeken. 50(9). 1596–1602. 45 indexed citations
9.
Dooley, Audrey, Shiwen Xu, Thomas H. Tranah, et al.. (2010). Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate. Lara D. Veeken. 49(11). 2024–2036. 57 indexed citations
10.
Valerio, Christopher, et al.. (2010). Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension. Lara D. Veeken. 49(11). 2147–2153. 9 indexed citations
11.
Xu, Shiwen, Mark Eastwood, Richard Stratton, et al.. (2009). Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts. Lara D. Veeken. 49(2). 259–263. 54 indexed citations
12.
Nihtyanova, Svetlana I., et al.. (2009). A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis. Lara D. Veeken. 48(10). 1218–1221. 31 indexed citations
13.
Nihtyanova, Svetlana I., et al.. (2006). Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis. Lara D. Veeken. 46(3). 442–445. 126 indexed citations
14.
Denton, C.P., et al.. (2004). Scleroderma—clinical and pathological advances. Best Practice & Research Clinical Rheumatology. 18(3). 271–290. 109 indexed citations
15.
Denton, C.P.. (2004). Scleroderma?clinical and pathological advances. Best Practice & Research Clinical Rheumatology. 18(3). 271–290. 19 indexed citations
16.
Swale, V.J., et al.. (2003). Etanercept-induced systemic lupus erythematosus. Clinical and Experimental Dermatology. 28(6). 604–607. 56 indexed citations
17.
Denton, C.P.. (2003). Transgenic analysis of scleroderma: understanding key pathogenic events in vivo. Autoimmunity Reviews. 3 indexed citations
18.
Tiwari, Alok, C.P. Denton, C. M. Black, et al.. (2003). Differentiation of primary and secondary Raynaud's disease by carotid arterial stiffness. European Journal of Vascular and Endovascular Surgery. 25(4). 336–341. 19 indexed citations
19.
Gregson, Norman A., Sidney Leibowitz, M C Kennedy, & C.P. Denton. (1985). A specific subset of neurons defined by a monoclonal antibody from patients with polyneuropathy and associated paraproteinaemia. Biochemical Society Transactions. 13(2). 461–462. 1 indexed citations
20.
Uricchio, Joseph F., Robert S. Litwak, C.P. Denton, Harvey A. Goldberg, & William Likoff. (1956). A MEDICAL APPRAISAL OF TRANSAORTIC COMMISSUROTOMY. Annals of Internal Medicine. 44(5). 844–860. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppina Abignano Breakdown of academic impact, for papers by Karin Melsens Breakdown of academic impact, for papers by Ikuko Hayakawa Breakdown of academic impact, for papers by Cecília Varjú Breakdown of academic impact, for papers by Angela Kill Breakdown of academic impact, for papers by Solène Tatibouet Breakdown of academic impact, for papers by G. Riemekasten Breakdown of academic impact, for papers by Tatiana Nevskaya Breakdown of academic impact, for papers by Catherine Alderdice Breakdown of academic impact, for papers by Satoshi Ebata
Rankless by CCL
2026